| 摘要 |
<p>NEW MATERIAL:An acidic glycoprotein capable of bonding to a monoclonal antibody obtained from a hybridoma cell in which an animal spleen cell immunized with erythropoietin(EPO) is fused with a myeloma cell, being >=88000 (unit/mg protein) in EPO ratio activity, capable of providing a single band by electrophoresis on sodium dodecylsulfate(SDS) and having 30000-40000 molecular weight. USE:A medicine applicable to anemia patient, patient after operation, etc. PREPARATION:An animal spleen cell immunized with EPO obtained from urine of anemia patient, etc., is fused with an animal myeloma cell and then a monoclonal antibody is produced in the resultant hybridoma cell. Then the antibody is bonded to an absorbing support to prepare an antibody-bonded absorbent and the absorbent is brought into contact with an EPO-containing raw material.</p> |
